//Your Connection to the Life Sciences Industry
Connect to IBC:LinkedIn iconTwitter iconFacebook iconBlog iconRSS icon


Welcome to our products section. Browse a list of current events and courses below. To narrow the list of events by topic, simply click on the relevant link in the left menu.
  • TIDES: Oligonucleotide and Peptide Therapeutics
    May 09-12, 2016
    Long Beach Convention & Entertainment Center, Long Beach, CA
    TIDES is the industry's #1 forum for oligonucleotide and peptide leaders to build successful partnerships and accelerate products from early discovery through late-stage development and commercialization.
  • ReTHINKing Bioprocessing Educational Series: Advancements in Protein Quality Control (by invitation only)
    May 24, 2016
    Marriott Heidelberg, Heidelberg, Baden-Wurttemberg, DE
    For more than 100 years, BD Biosciences - Advanced Bioprocessing has helped biopharmaceutical companies enhance complex media formulations with unique supplements and feeds to improve yield and reduce variability. Our products have been used in batch, fed-batch and perfusion processes across a number of applications to improve protein production and quality. (By invitation only)
  • Next Generation Protein Therapeutics
    June 13-15, 2016
    Parc 55 Hilton, San Francisco, CA
    This conference is the industry's most innovative and comprehensive conference for sharing best practices and new ideas to accelerate the discovery, engineering and development of alternative scaffolds and novel protein therapeutics to create differentiated drugs.
  • Bioconjugates: From Targets to Therapeutics
    June 13-15, 2016
    Parc 55 Hilton, San Francisco, CA
    This conference focuses on discovery, design, development and CMC manufacturing issues of antibody-drug conjugates and many other types of bioconjugates, in order to facilitate information sharing and help companies move their programs forward.
  • Cell Line Development & Engineering
    June 13-15, 2016
    Parc 55 Hilton, San Francisco, CA
    The leading forum to gather the global cell line industry together under one roof to actively discuss, understand and utilize these novel techniques and tools.
  • BioProcess International Conference & Exposition
    October 04-07, 2016
    Boston Convention and Exhibition Center, Boston, MA
    BPI is engineered to be exactly what you need it to be... Only the largest bioprocessing event brings you new ideas, demystifies technology, and fosters partnerships in highly interactive formats to move drug candidates closer to approval.
  • Cell & Gene Therapy BioProcessing & Commercialization
    October 05-07, 2016
    Boston Convention and Exhibition Center, Boston, MA
    IBC's Cell Therapy Bioprocessing conference has built a reputation of providing a first-rate faculty of participants, who collectively share perspectives and lessons learned from detailed case studies to help you overcome the challenges, develop the strategies and implement the technologies to propel this field towards commercial sustainability.
  • Next Generation Cancer Immuno Therapies
    October 05-07, 2016
    Boston Convention and Exhibition Center, Boston, MA
    Providing insights on the latest advances in cancer immunotherapies, IBC's Immuno-Oncology meeting will focus on overcoming challenges with discovery, development, approval, and product launch. Discussions will cover methods to improve efficacy, potency, and viability of potential therapeutic candidates.
  • Well Characterized Biologicals
    November 03-04, 2016
    The Westin Arlington Gateway, Arlington, VA
    Well Characterized Biologicals is the industry's most trusted and longest running event to gain the regulatory guidance and analytical characterization strategies you need to ensure accurate CMC submissions.
  • Antibody Engineering & Therapeutics
    December 11-15, 2016
    Manchester Grand Hyatt San Diego, San Diego, CA
    IBC's Antibody Engineering & Therapeutics conference is an invaluable resource for your research programs. Attending these meetings means getting important updates from the early stage work of leading academic researchers and tracking the progress of companies advancing antibody therapeutics through clinical development. Covering both cutting-edge developments in the basic science of antibody engineering and clinical/preclinical updates of therapeutic antibodies in development.